Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
4.390
-0.060 (-1.39%)
Feb 11, 2025, 2:05 PM EST - Market open

Company Description

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt.

The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Zhengye Biotechnology Holding Limited
Zhengye Biotechnology Holding logo
Country China
Founded 2004
IPO Date Jan 7, 2025
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 286
CEO Songlin Song

Contact Details

Address:
No.1 Lianmeng Road, Jilin Economic & Technical Development Zone
Jilin, 132101
China
Phone 86 432 6304 7008
Website jlzybio.com

Stock Details

Ticker Symbol ZYBT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency CNY
IPO Price $4.00
CIK Code 0001975641
SIC Code 2834

Key Executives

Name Position
Zhenfa Han Director and Chairman of the Board
Songlin Song Chief Executive Officer
Wenhua Sun Director
Ping Wang Chief Financial Officer
Zhongyao Liu Vice General Manager
Wei Lian Vice General Manager
Yawen Dong Vice General Manager
Yuyou He Vice General Manager
Wanlin Zhang Vice General Manager
Yuhong Cheng Vice General Manager

Latest SEC Filings

Date Type Title
Jan 14, 2025 6-K Report of foreign issuer
Jan 8, 2025 6-K Report of foreign issuer
Jan 7, 2025 424B4 Prospectus
Jan 6, 2025 CERT Certification by an exchange approving securities for listing
Dec 20, 2024 EFFECT Notice of Effectiveness
Dec 19, 2024 8-A12B Registration of securities
Dec 9, 2024 POS AM Post-Effective amendments for registration statement
Nov 21, 2024 FWP Free Writing Prospectus
Nov 15, 2024 POS AM Post-Effective amendments for registration statement
Sep 30, 2024 EFFECT Notice of Effectiveness